The store will not work correctly when cookies are disabled.
(L)-3-thienylglycine
ID: ALA4102130
Cas Number: 1194-87-2
PubChem CID: 16220058
Product Number: S132456, Order Now?
Max Phase: Preclinical
Molecular Formula: C6H7NO2S
Molecular Weight: 157.19
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N[C@H](C(=O)O)c1ccsc1
Standard InChI: InChI=1S/C6H7NO2S/c7-5(6(8)9)4-1-2-10-3-4/h1-3,5H,7H2,(H,8,9)/t5-/m0/s1
Standard InChI Key: BVGBBSAQOQTNGF-YFKPBYRVSA-N
Molfile:
RDKit 2D
10 10 0 0 0 0 0 0 0 0999 V2000
8.7863 -6.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0695 -5.2700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5072 -6.1006 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3527 -6.5135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0695 -6.1005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7874 -7.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1228 -7.8272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3787 -8.6115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2037 -8.6104 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.4576 -7.8255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 5 1 0
5 4 1 0
1 3 1 0
5 2 2 0
1 6 1 1
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 6 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 157.19 | Molecular Weight (Monoisotopic): 157.0197 | AlogP: 0.83 | #Rotatable Bonds: 2 |
Polar Surface Area: 63.32 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.34 | CX Basic pKa: 8.31 | CX LogP: -1.69 | CX LogD: -1.73 |
Aromatic Rings: 1 | Heavy Atoms: 10 | QED Weighted: 0.67 | Np Likeness Score: -1.30 |
References
1. (2014) D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, |